These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17429424)

  • 1. Iodixanol vs ioxaglate for preventing contrast nephropathy: who is winner?
    Jo SH; Koo BK; Youn TJ; Kim HS
    Kidney Int; 2007 Apr; 71(8):828; author reply 828-9. PubMed ID: 17429424
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
    Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
    J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media.
    Liss P; Persson PB; Hansell P; Lagerqvist B
    Kidney Int; 2006 Nov; 70(10):1811-7. PubMed ID: 17003814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visipaque (iodixanol) and hexabrix (ioxaglate) in renal insufficiency.
    Deray G
    J Am Coll Cardiol; 2007 Apr; 49(15):1668. PubMed ID: 17433961
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in coronary angiography.
    Persson P; Liss P; Hansell P
    J Am Coll Cardiol; 2007 Apr; 49(15):1668-1669. PubMed ID: 17433962
    [No Abstract]   [Full Text] [Related]  

  • 6. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
    Giustino G; Baber U; Mastoris I; Vlachojannis GJ; Yu J; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Nikolsky E; Wong SC; Theodoropoulos KN; Dangas GD; Mehran R
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):703-9. PubMed ID: 26481591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of iodixanol (Visipaque) and ioxaglate (Hexabrix) in coronary angiography and ventriculography: a double-blind randomized study].
    Roriz R; de Gevigney G; Finet G; Nantois-Collet C; Borch KW; Amiel M; Beaune J
    J Radiol; 1999 Jul; 80(7):727-32. PubMed ID: 10431273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of the iodinated contrast agents Ioxaglate, Iohexol and Iodixanol on thrombus formation and fibrinolysis.
    Jones CI; Goodall AH
    Thromb Res; 2003; 112(1-2):65-71. PubMed ID: 15013276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration.
    Lasser EC; Lyon SG; Berry CC
    Radiology; 1997 Jun; 203(3):605-10. PubMed ID: 9169676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml.
    Tveit K; Bolz KD; Bolstad B; Haugland T; Berg KJ; Skjaerpe T; Kloster YF
    Acta Radiol; 1994 Nov; 35(6):614-8. PubMed ID: 7946687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast media-induced ventricular fibrillation: an experimental study of the effects of dimeric contrast media during wedged catheter injection in dogs.
    Pedersen HK; Jacobsen EA; Refsum H
    Acad Radiol; 1994 Oct; 1(2):136-44. PubMed ID: 9419477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of anticoagulation on ionic and nonionic contrast media effect on thrombogenesis and fibrinolysis: The PEPCIT study.
    Bellemain-Appaix A; Beygui F; Lesty C; Gupta S; Silvain J; Le Feuvre C; Cayla G; Allali Y; Montalescot G; Collet JP
    Catheter Cardiovasc Interv; 2012 Apr; 79(5):823-33. PubMed ID: 21618678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial.
    Davidson CJ; Laskey WK; Hermiller JB; Harrison JK; Matthai W; Vlietstra RE; Brinker JA; Kereiakes DJ; Muhlestein JB; Lansky A; Popma JJ; Buchbinder M; Hirshfeld JW
    Circulation; 2000 May; 101(18):2172-7. PubMed ID: 10801758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet degranulation induced by some contrast media is independent of their nonionic vs ionic nature.
    Grabowski EF; Jang IK; Gold H; Palacios IF; Boor SE; Rodino LJ; Michelson AD
    Acta Radiol Suppl; 1995; 399():182-4. PubMed ID: 8610512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac events after low osmolar ionic or isosmolar nonionic contrast media utilization in the current era of coronary angioplasty.
    Le Feuvre C; Batisse A; Collet JP; Batisse JP; Choussat R; Beygui F; Helft G; Montalescot G; Metzger JP
    Catheter Cardiovasc Interv; 2006 Jun; 67(6):852-8. PubMed ID: 16649230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albuminuria following nephroangiography with low osmolar contrast media in the rat.
    Holtz E; Heglund IF; Golman K
    Acta Radiol Suppl; 1987; 370():57-9. PubMed ID: 2980313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of iodixanol and ioxaglate for adult aortography and renal/visceral angiography: a phase III clinical trial.
    Siegel EL; Rosenblum JD; Eckard DA; Leef J; Bergh J; Parsa MB; Redick ML
    Acad Radiol; 1996 Sep; 3 Suppl 3():S507-13. PubMed ID: 8883529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conclusion of recent 'osmolality trials' in preventing contrast-induced nephropathy by NAC--what is the standard?
    Jo SH; Koo BK; Youn TJ; Kim HS
    Nephrol Dial Transplant; 2008 Jul; 23(7):2424; author reply 2424-5. PubMed ID: 18445639
    [No Abstract]   [Full Text] [Related]  

  • 19. Incompatibility of contrast medium and trisodium citrate.
    Delcour C; Bruninx G
    Cardiovasc Intervent Radiol; 2013 Feb; 36(1):237-8. PubMed ID: 22696011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization.
    Sutton AG; Finn P; Grech ED; Hall JA; Stewart MJ; Davies A; de Belder MA
    Am Heart J; 2001 Apr; 141(4):677-83. PubMed ID: 11275937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.